Heidi's Free Tier Advantage

Heidi’s free plan is less a monetization choice than a distribution weapon. In AI scribes, the hard part is getting a doctor to trust the note after a real patient visit, so unlimited transcription and basic notes remove the trial decision entirely. That lets Heidi spread doctor by doctor, then convert heavier users and larger groups into paid seats, admin tools, and enterprise contracts, while Freed started with a direct $99 per month purchase for the same independent clinic buyer.1 2 3 4

• The economics of the category make free viable at the top of funnel. These products replace transcription and hours of daily charting work, but small practices are price sensitive and often want to spend only modest amounts on software, so removing the first payment increases adoption sharply.3 4
• Heidi’s motion is broader than a solo doctor self serve sale. It layers paid clinician plans with practice and enterprise sales, and it has used that mix to reach an estimated $50M ARR by March 2026, ahead of Freed’s estimated $33M ARR by August 2026.1 2
• This also reflects where the category is going. Basic scribing is becoming bundled into larger products, so both companies are adding adjacent tools. Freed is building for independent clinics with coding, evidence, and front desk workflows, while Heidi is extending into research, coding, and patient communications.1 2 5

Going forward, the winners are likely to be the companies that turn a free or cheap note taker into a broader workflow hub. Heidi’s free entry point gives it more chances to widen from one clinician into a whole practice or health system, which puts pressure on Freed to keep bundling more value around its core scribe product.1 2 5